Antibodies
5 December 2016
Mersana Presents Updated Data on Investigational Cancer Antibody Drug Conjugate at World Conference on Lung Cancer5 December 2016
Aduro Biotech Announces Anti-CD27 Agonist, an Investigational Anti-Cancer Immunotherapy, Advancing in Collaboration with MSD5 December 2016
Kymab new therapeutic antibody for autoimmune diseases shows potential for improvement in post-transplant survival5 December 2016
New interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product5 December 2016
INNATE PHARMA: Further clinical data for lirilumab and IPH4102 presented at ASH annual meeting4 December 2016
Novartis SEG101 (crizanlizumab, formerly SelG1) significantly reduces frequency of sickle cell pain crises in Phase II study2 December 2016
Surface Oncology CD47 Program Demonstrates Promising Anti-Tumor Activity in Hematological Disease Models1 December 2016
Agenus Announces Commencement of Phase 1/2 Clinical Trial of anti-OX40 Checkpoint Antibody INCAGN1949 in Patients with Solid Tumors1 December 2016
PharmaMar Presents Positive Results With Its Conjugated Antibody MI130110 in CD13-Expressing Tumor-Cells1 December 2016
Protalix BioTherapeutics Enrolls First Patient in Phase II Clinical Trial of OPRX-106 for the Treatment of Ulcerative Colitis30 November 2016
Global First IND for Subcutaneous Injectable anti-PD-L1 Domain Antibody Receives FDA Approval30 November 2016
First clinical data for monalizumab as a single agent in cancer patients show favorable safety profileNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports